Concarlo Holdings

BioCentury: Concarlo: Targeting proliferationand resistance in one go. Allamneni is a biopharma R&D expert with almost 20+ IND/IMPD submissions, 6 NDA/MAA approvals, and a track record of efficiently developing therapeutic candidates of various modalities. Natalia specializes in liposome and lipid nanoparticle drug delivery systems. Natalia has over 20 years of experience in lipid nanoparticle drug delivery field and has been involved in all aspects of liposome manufacturing, starting from early-stage formulation design, process development, scale-up and early clinical manufacturing. Kate Coleman is a cell and molecular biologist with research background in cell cycle control and mechanisms regulating genome integrity. Kate is passionate about oncology research and the development of therapeutic tools to manipulate cell proliferation in cancer treatment. Carolina Guido is a molecular biologist with a strong background in molecular and cellular biology. Janice Lansita is a board-certified toxicologist with over 17 years of experience both in the biopharmaceutical industry and with the Food and Drug Administration (FDA).